Showing results (111-120 of 673) with videos related to

Sort By:
Pageof 68
HIV Clinical Trials|July 11, 2007
Systematic review of strategies to measure HIV-related diarrheaJill Tinmouth, Gabor Kandel, George Tomlinson, et al.
HIV Clinical Trials|February 11, 2009
Objective assessment of facial lipoatrophy changes in a cohort of HIV-infected patients taking combination antiretroviral therapyYong Yang, Marline Yap, Naing Oo Tha, et al.
HIV Clinical Trials|February 11, 2009
Upper gastrointestinal bleeding may unmask didanosine-associated portal hepatopathy in HIV/HCV co-infected patientsEugenia Vispo, Ivana Maida, Pablo Barreiro, et al.
HIV Clinical Trials|April 14, 2009
A randomized, double-blind, placebo-controlled study of benfluorex in HIV-infected patients with insulin resistance or impaired glucose toleranceI Poizot-Martin, M P Drogoul-Vey, D Di Stefano, et al.
HIV Clinical Trials|August 8, 2015
Effects of raltegravir combined with tenofovir/emtricitabine on body shape, bone density, and lipids in African-Americans initiating HIV therapyLaura Young, David A Wohl, William B Hyslop, et al.
HIV Clinical Trials|July 20, 2017
The REVAMP trial to evaluate HIV resistance testing in sub-Saharan Africa: a case study in clinical trial design in resource limited settings to optimize effectiveness and cost effectiveness estimatesMark J Siedner, Mwebesa B Bwana, Mahomed-Yunus S Moosa, et al.
HIV Clinical Trials|September 12, 2017
Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128)Rima Kulkarni, Sally L Hodder, Huyen Cao, et al.
HIV Clinical Trials|July 28, 2015
Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexityKaren T Tashima, Katie R Mollan, Lumine Na, et al.
HIV Clinical Trials|June 9, 2016
Can Probiotics Reduce Inflammation and Enhance Gut Immune Health in People Living with HIV: Study Designs for the Probiotic Visbiome for Inflammation and Translocation (PROOV IT) Pilot TrialsConnie J Kim, Sharon L Walmsley, Janet M Raboud, et al.
HIV Clinical Trials|August 22, 2014
Efficacy and safety of darunavir/ritonavir plus etravirine dual regimen in antiretroviral therapy-experienced patients: a multicenter clinical experienceLidia Gazzola, Paola Cicconi, Diego Ripamonti, et al.
Pageof 68